Literature DB >> 32430425

What do differences in case fatality ratios between children and adults tell us about COVID-19?

Stefan Ebmeier1, Aubrey J Cunnington2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32430425      PMCID: PMC7241110          DOI: 10.1183/13993003.01601-2020

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
To the Editor: Cristiani et al. [1] have raised interesting questions in their editorial discussing the differences in coronavirus disease 2019 (COVID-19) morbidity and mortality between children and adults. The authors proposed a number of possible reasons to explain why children suffer less severe illness, including age-related variation in angiotensin-converting enzyme (ACE)2 receptor expression, trained immunity, and differences in lymphocyte and natural killer cell abundance. Whilst these hypotheses may be correct, we wish to challenge the notion that greater morbidity and mortality in adults is a remarkable feature of COVID-19. This is, in fact, the typical situation for most infections occurring in the absence of prior immunity. The novel COVID-19 virus emerged into a previously unexposed and presumably fully susceptible population at the end of 2019, facilitating its rapid spread around the world. It has since been well documented that children with COVID-19 suffer a milder illness than adults, with better clinical outcomes overall. Age-specific case fatality ratios appear to increase continuously from close to 0% in children aged <10 years to ∼13% in adults aged ≥80 years [2]. Globally, children suffer the greatest burden of most infectious diseases, particularly respiratory infections; hence, the low burden of COVID-19 in children has been viewed by many as surprising. However, for most common infectious diseases, the relationships between age and disease severity are influenced by acquisition of immunity, and because immunity is dependent on exposure it therefore increases with age. When only susceptible individuals are considered, age-specific mortality rates are typically higher in adults than in children for most infectious diseases. This was observed for measles in historical first-contact island epidemics [3], and more recently for emerging infectious diseases including severe acute respiratory syndrome (SARS) [4], West Nile virus infection [5], and severe fever with thrombocytopenia syndrome (SFTS) [6]. Similar relationships are clear even for common infections causing their greatest burden in childhood, such as primary varicella infection [7] and Plasmodium falciparum malaria [8], when individuals without prior immunity are considered. We believe that the greater burden of COVID-19 in adults primarily reflects the fact that the whole population is susceptible, rather than an unusual association between severity and age. Until we have better epidemiological data to be certain about denominators (numbers of infections in different age groups), it will be difficult to discern whether the relationship between age and case fatality ratio is monotonic or “J” shaped (with a higher case fatality ratio in the very youngest children compared with older children). However, comparisons between different age groups may tell us more about age-related host–pathogen interactions in general, than about the pathogenesis of COVID-19 specifically. This one-page PDF can be shared freely online. Shareable PDF ERJ-01601-2020.Shareable
  8 in total

1.  Epidemiology of Varicella-Zoster Virus in England and Wales.

Authors:  M Brisson; W J Edmunds
Journal:  J Med Virol       Date:  2003       Impact factor: 2.327

2.  Surveillance for human West Nile virus disease - United States, 1999-2008.

Authors:  Nicole P Lindsey; J Erin Staples; Jennifer A Lehman; Marc Fischer
Journal:  MMWR Surveill Summ       Date:  2010-04-02

3.  Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011-17: a prospective observational study.

Authors:  Hao Li; Qing-Bin Lu; Bo Xing; Shao-Fei Zhang; Kun Liu; Juan Du; Xiao-Kun Li; Ning Cui; Zhen-Dong Yang; Li-Yuan Wang; Jian-Gong Hu; Wu-Chun Cao; Wei Liu
Journal:  Lancet Infect Dis       Date:  2018-07-24       Impact factor: 25.071

4.  Age-specific measles mortality during the late 19th-early 20th centuries.

Authors:  G D Shanks; M Waller; H Briem; M Gottfredsson
Journal:  Epidemiol Infect       Date:  2015-04-13       Impact factor: 4.434

5.  Risk factors for mortality from imported falciparum malaria in the United Kingdom over 20 years: an observational study.

Authors:  Anna M Checkley; Adrian Smith; Valerie Smith; Marie Blaze; David Bradley; Peter L Chiodini; Christopher J M Whitty
Journal:  BMJ       Date:  2012-03-27

6.  Estimates of the severity of coronavirus disease 2019: a model-based analysis.

Authors:  Robert Verity; Lucy C Okell; Ilaria Dorigatti; Peter Winskill; Charles Whittaker; Natsuko Imai; Gina Cuomo-Dannenburg; Hayley Thompson; Patrick G T Walker; Han Fu; Amy Dighe; Jamie T Griffin; Marc Baguelin; Sangeeta Bhatia; Adhiratha Boonyasiri; Anne Cori; Zulma Cucunubá; Rich FitzJohn; Katy Gaythorpe; Will Green; Arran Hamlet; Wes Hinsley; Daniel Laydon; Gemma Nedjati-Gilani; Steven Riley; Sabine van Elsland; Erik Volz; Haowei Wang; Yuanrong Wang; Xiaoyue Xi; Christl A Donnelly; Azra C Ghani; Neil M Ferguson
Journal:  Lancet Infect Dis       Date:  2020-03-30       Impact factor: 25.071

7.  Case fatality of SARS in mainland China and associated risk factors.

Authors:  Na Jia; Dan Feng; Li-Qun Fang; Jan Hendrik Richardus; Xiao-Na Han; Wu-Chun Cao; Sake J de Vlas
Journal:  Trop Med Int Health       Date:  2009-04-17       Impact factor: 2.622

8.  Will children reveal their secret? The coronavirus dilemma.

Authors:  Luca Cristiani; Enrica Mancino; Luigi Matera; Raffaella Nenna; Alessandra Pierangeli; Carolina Scagnolari; Fabio Midulla
Journal:  Eur Respir J       Date:  2020-04-23       Impact factor: 16.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.